Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04688450 · ClinicalTrials.gov registry record · NA
BP Management System User Acceptance Testing
A NA study of Hypotension and Shock, sponsored by Andrew Tomas Reisner.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04688450 is a NA study of Hypotension and Shock that has completed, run by Andrew Tomas Reisner. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04688450, a NA study of Hypotension and Shock, has completed, sponsored by Andrew Tomas Reisner.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a feasibility study for an investigational clinical decision support system ("the System") intended to optimize the management of blood pressure (BP) for patients during vasopressor infusion. The investigational outcomes are the perceptions of the nurse-subjects who are managing the BP of the patient-subjects; the operational performance of the System; and any technical failures of the software during real-time operation.
Conditions Studied
Interventions
- DEVICE VIGORIS Blood Pressure Management Clinical Decision Support System
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-01-21 |
| Est. Completion | 2023-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04688450
The ClinicalTrials.gov registry entry for NCT04688450 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Andrew Tomas Reisner, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypotension and Shock appearing as the primary indexed condition, and to 1 intervention - of which VIGORIS Blood Pressure Management Clinical Decision Support System is the first listed.
NCT04688450 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04688450 about?
NCT04688450 is a clinical study titled "BP Management System User Acceptance Testing". This is a feasibility study for an investigational clinical decision support system ("the System") intended to optimize the management of blood pressure (BP) for patients during vasopressor infusion. The investigational outcomes are the perceptions of the nurse-subjects who are managing the BP of th...
What is the current status of trial NCT04688450?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-01-21. Estimated completion is 2023-05-31.
What conditions does trial NCT04688450 study?
This clinical trial studies the following conditions: Hypotension and Shock.
What interventions are being tested in trial NCT04688450?
The interventions under investigation include: VIGORIS Blood Pressure Management Clinical Decision Support System (DEVICE).
Who is sponsoring clinical trial NCT04688450?
This trial is sponsored by Andrew Tomas Reisner, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04688450 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypotension and Shock
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.